RankingsPricing
  1. US-listed companies
  2. Organogenesis Holdings Inc.
  3. Raw

Organogenesis Holdings Inc.ORGO

Market cap
$655.83M
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Revenues--193261338468451433482
Cost of Revenue--697687114105106116
Gross profit--125185251354346327366
Selling, general and administrative--162200203250284270295
Research and development--11152031404450
Impairment charge--------19
Write down of capitalized internal-use software costs--------4
Total operating expenses208,6985176214224281324314368
Income (loss) from operations--4,591,834-52-2927732213-1
Interest expense, net--------2
Other income (expense), net--000-0-000
Total other expense, net---13-11-9-9-2-2-2
Net income (loss) before income taxes---65-4018642010-3
Income tax (expense) benefit--001-3155-4
Net income and comprehensive income-208,698-2,093,913-65-4018951651
Accretion of redeemable convertible preferred stock to redemption value--------0
Cumulative dividend on redeemable convertible preferred stock--------1
Net Income (Loss) Available to Common Stockholders, Basic, Total----411895---1
Net Income (Loss) Available to Common Stockholders, Diluted---------1
Basic----0.170.740.120.04-0.01
Diluted----0.160.710.120.04-0.01